LYOMYXOVAX
LYOMYXOVAX
Not authorised
- Water for injection
- Shope fibroma virus, Live
Product identification
Medicine name:
LYOMYXOVAX
Active substance:
- Water for injection
- Shope fibroma virus, Live
Target species:
-
Rabbit (exclusively kept as pet)
-
Rabbit (for reproduction)
-
Rabbit
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Water for injection0.50/millilitre(s)1.00unit(s)
-
Shope fibroma virus, Live2.70/log10 (50% cell culture infectious dose)/dose1.00unit(s)
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Rabbit (exclusively kept as pet)
-
Rabbit (for reproduction)
-
All relevant tissues0day
-
-
Rabbit
-
All relevant tissues0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI08AD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
-
Surrendered
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/6230954 7/1982
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 24/03/2022
How useful was this page?:
